Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-11-30 | $31,566,321 | reported | |
| FY 2024 | 2024-11-30 | $31,986,106 | reported | |
| FY 2023 | 2023-11-30 | $31,343,695 | reported | |
| FY 2022 | 2022-11-30 | $30,336,749 | reported | |
| FY 2021 | 2021-11-30 | $28,884,902 | reported | |
| FY 2020 | 2020-11-30 | $31,147,593 | reported | |
| FY 2019 | 2019-11-30 | $31,816,571 | reported | |
| FY 2018 | 2018-11-30 | $29,218,490 | reported | |
| FY 2017 | 2017-11-30 | $25,384,279 | reported | |
| FY 2016 | 2016-11-30 | $23,128,047 | reported | |
| FY 2015 | 2015-11-30 | $21,091,431 | reported | |
| FY 2014 | 2014-11-30 | $20,126,546 | reported |
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Twelve months to May 31, 2026 · derived
Cryo Cell International Inc is the 6th largest of the 14 covered companies the SEC files under this code, by revenue. SIC 8090
Latest filing Sep 14, 2026
The us-gaap concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | $3.23M | $169.50K | $3.40M | — | 8.06M sh | −0.3% | 64.8% |
| FY2024 | $2.02M | $1.42M | $3.44M |
| $0.25 |
| 8.08M sh |
| −2.5% |
| 95.5% |
| FY2023 | $0.00 | $799.04K | $799.04K | — | 8.29M sh | −1.9% | 38.4% |
| FY2022 | $7.67M | $1.82M | $9.49M | $0.90 | 8.44M sh | −0.7% | — |
| FY2021 | $0.00 | $249.38K | $249.38K | — | 8.50M sh | +12.3% | 4.1% |
1 manager · Quarter ended Sep 30, 2026All holders ›
0No reported open-market purchases or sales in the last 12 months.